MPS II Immunophenotyping
study id #: NCT04976231
condition: MPS II, Mucopolysaccharidosis II, Hunter Syndrome
status: Not yet recruiting
purpose:The purpose of this study is to investigate how participant’s body’s immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.
results: https://clinicaltrials.gov/ct2/show/results/NCT04976231
last updated: February 26, 2022
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities fo...Mucopolysaccharidosis type II (MPS II) r...
-
Morquio Syndrome Type A Overviewhttps://www.youtube.com/watch?v=i0vsm2G5...
-
Establishing a Core Outcome set for Mucopolysaccharidoses (MPS) in Children: Study Protocol for a Rapid Literature R...Mucopolysaccharidoses (MPS) are a group ...
-
Oxidative Stress in Mucopolysaccharidoses: Pharmacological ImplicationsAlthough mucopolysaccharidoses (MPS) are...
-
International MPS NetworkCreated in April 1992 by Christine Laver...
-
Mucopolysaccharidosis Type III – Sanfilippo SyndromeMucopolysaccharidosis type III (MPS III)...
-
Significant Neuropsychiatric Symptoms: Three Mucopolysaccharidosis Type IIIB Cases, Two of Whom Were Siblings With a...Mucopolysaccharidosis (MPS) type IIIB pa...